KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $507.6 million.

  • Biogen's Non-Current Deferred Tax Liability rose 16645.67% to $507.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $507.6 million, marking a year-over-year increase of 16645.67%. This contributed to the annual value of $507.6 million for FY2025, which is 16645.67% up from last year.
  • Per Biogen's latest filing, its Non-Current Deferred Tax Liability stood at $507.6 million for Q4 2025, which was up 16645.67% from $358.1 million recorded in Q3 2025.
  • Biogen's Non-Current Deferred Tax Liability's 5-year high stood at $966.7 million during Q1 2021, with a 5-year trough of $118.3 million in Q2 2025.
  • Its 5-year average for Non-Current Deferred Tax Liability is $513.7 million, with a median of $539.4 million in 2022.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first surged by 31042.39% in 2024, then tumbled by 7996.95% in 2025.
  • Quarter analysis of 5 years shows Biogen's Non-Current Deferred Tax Liability stood at $694.5 million in 2021, then plummeted by 51.81% to $334.7 million in 2022, then skyrocketed by 91.75% to $641.8 million in 2023, then plummeted by 70.32% to $190.5 million in 2024, then soared by 166.46% to $507.6 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $507.6 million for Q4 2025, versus $358.1 million for Q3 2025 and $118.3 million for Q2 2025.